Clinical Trials on Urological Malignancies in United States
Total 7790 results
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingTotal Exenteration | Anterior or Posterior Pelvic Exenteration | Gynecologic Malignancies | Colorectal Malignancies | Urologic MalignanciesUnited States
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
AgennixTerminatedMalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Bristol-Myers SquibbCompletedAdvanced MalignanciesUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Case Comprehensive Cancer CenterCompletedHepatic MalignanciesUnited States
-
Metronome TherapeuticsUnknownNonhematologic MalignanciesUnited States
-
Massachusetts General HospitalClinical GenomicsWithdrawnGastrointestinal MalignanciesUnited States
-
University of Southern CaliforniaTerminated
-
Novartis PharmaceuticalsCompletedAdvanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Pathway Therapeutics, Inc.Completed
-
University of PittsburghAmerican College of Radiation OncologyNot yet recruitingUpper Abdominal MalignanciesUnited States
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Weill Medical College of Cornell UniversityTerminatedSolid Tumor MalignanciesUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
Symphony Evolution, Inc.Completed
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Geron CorporationCompletedSolid Tumor MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnHistologically-confirmed MalignanciesUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
Georgetown UniversityPfizerUnknownAdvanced Solid Tumor MalignanciesUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Novartis PharmaceuticalsTerminated